In this Michigan Medicine Health Lab article, hematologist Matthew Pianko, M.D., from the University of Michigan Health Rogel Cancer Center discusses groundbreaking advances in multiple myeloma treatment. He highlights new immune-targeting drugs, CAR T-cell therapy, genetic insights, and expanded access to clinical trials. With survival rates improving significantly, these innovations offer hope for better, more personalized care.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.